
Thymosin alpha-1
Natural thymic peptide studied for balanced immune responses and T-cell development.
For Research Use Only
Sold strictly for laboratory research. Not for human or veterinary use, ingestion, or clinical/diagnostic application.
The lower price is applied automatically once your cart holds 5 or more of this vial.
Bacteriostatic water included
About this peptide
Thymosin alpha-1 is a naturally occurring peptide made up of 28 amino acids and associated with the thymus, an organ involved in immune development. Researchers study how it influences T cells and the signals used by the immune system to recognise and respond to threats. Work also examines how it may help balance early and longer-term immune responses.
Why researchers reach for Thymosin alpha-1
T-cell maturation
Referenced in thymocyte differentiation studies.
TLR pathway
Modulates TLR2 and TLR9 signaling in vitro.
Immune balance
Adjusts Th1/Th2/Treg profiles in preclinical models.
Key features
- ≥99% HPLC purity
- Acetylated 28-mer thymic peptide
- Mass-spec verified
- Cold-chain dispatch
How it works
TLR engagement
Acts as TLR agonist on dendritic cells.
NK-cell activity
Enhances natural-killer cytotoxicity markers in vitro.
Cytokine tuning
Shifts IFN-γ, IL-2, and IL-10 expression.
Research dosage guidelines
Reference ranges only — reproduced from published preclinical literature. Not a recommendation for human use.
| Range | Reported dose | Note |
|---|---|---|
| Typical reconstitution | 2 mL bacteriostatic water | Yields 5 mg/mL (5000 mcg/mL) |
| Reported research range | 0.8–1.6 mg, 1–2× weekly | Reference only |
Tracking this compound? Registered researchers can log active Thymosin alpha-1 protocols in their private Research Log.
Timing in research protocols
Twice weekly, spaced evenly; no time-of-day or meal relationship reported.
- Phase 3 trials and approved labelling specify 1.6 mg subcutaneously or intramuscularly twice weekly.
- Course lengths of 6 months (hepatitis B) and up to 12 months in combination regimens are documented.
- The twice-weekly interval reflects duration of immunomodulatory action, not circadian factors.
- Responses continued to develop after courses were completed, which is why the literature uses long courses rather than short ones.
Drawn from published research protocols and pharmacology literature. Reference information for laboratory research only — not an instruction or guidance for use.
Technical specifications
- Sequence
- Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN
- Molecular weight
- 3108.3 g/mol
- Purity
- ≥99% (HPLC)
- Form
- Lyophilized powder
- Vial size
- 10 mg
- Storage (lyophilised vial)
- Cool, dry and protected from light
- Storage (after reconstitution)
- 2–8°C
Published research
Peer-reviewed literature on Thymosin alpha-1. Links open in a new tab.
Research use notice
Sold for in vitro laboratory research only. Not for human or veterinary use, diagnosis, or therapy.
